NonprofitsMemorial Sloan-Kettering Cancer Center

Medical Research

Memorial Sloan-Kettering Cancer Center

NEW YORK, NY

Total revenue

Total expenses

Net assets

Grants received

$46.5M

163 grants

EIN

131624182

Tax year

Grants received

Showing 163 of 163

FromAmountPurposeYear
$1.6M
Extramural Research
2024
$1.4M
YOUNG INVESTIGATOR AWARD, LONG-TERM INTERNATIONAL FELLOWSHIP
2024
$585K
CANCER RESEARCH
2024
$171K
SUPPORT CHARITABLE PURPOSE
2024
$125K
TO SUPPORT MEDICAL RESEARCH STUDY
2024
$100K
MULTIPLE GRANTS FOR MULTIPLE PURPOSES
2024
$61K
INSTITUTIONAL SUPPORT FOR CANCER RESEARCH
2024
$57K
PROGRAMATIC SUPPORT
2024
$57K
PROGRAMATIC SUPPORT
2024
$56K
SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
2024
$50K
RESEARCH
2024
$2.0M
Extramural Research Grant
2023
$1.6M
RESEARCH SUPPORT/SUBAWARDS
2023
$1.5M
YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD
2023
$648K
RESEARCH SUPPORT
2023
$648K
RESEARCH SUPPORT
2023
$500K
CANCER RESEARCH
2023
$398K
SUB-AWARD
2023
$225K
RESEARCH GRANT
2023
$199K
SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
2023
$187K
RESEARCH
2023
$172K
PROGRAMATIC SUPPORT
2023
$131K
Research
2023
$76K
SUBAWARD
2023
$68K
MEDICAL/SCIENTIFIC RESEARCH & PROGRAMS
2023
$50K
WTS MID-CAREER INVESTIGATOR AWARD
2023
$48K
SUPPORT CHARITABLE PURPOSE
2023
$29K
Support of research activities
2023
$26K
FOR RECIPIENT'S EXEMPT PURPOSE
2023
$26K
INSTITUTIONAL SUPPORT FOR CANCER RESEARCH
2023
$25K
RESEARCH GRANT AWARD
2023
$24K
ATRIAL FIBRILLATION PROGRAM
2023
$1.4M
Extramural Research Grant
2022
$340K
CANCER RESEARCH
2022
$267K
CANCER RESEARCH
2022
$161K
SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
2022
$159K
RESEARCH
2022
$143K
PUBLIC HEALTH SCIENCES
2022
$143K
GENERAL OPERATING SUPPORT
2022
$139K
INSTITUTIONAL SUPPORT FOR CANCER RESEARCH
2022
$119K
Subaward
2022
$108K
VACCINE AND INFECTIOUS DISEASE RESEARCH
2022
$101K
TRANSLATIONAL SCIENCE & THERAPY
2022
$97K
SUPPORT CHARITABLE PURPOSE
2022
$70K
Support of research activities
2022
$60K
Medical Student Summer Research grants
2022
$58K
Research
2022
$40K
MEDICAL/SCIENTIFIC RESEARCH & PROGRAMS
2022
$37K
CLINICAL RESEARCH
2022
$27K
GENERAL PURPOSE
2022
$10K
RESEARCH SUPPORT
2022
$486K
PUBLIC HEALTH SCIENCES
2021
$450K
CANCER RESEARCH
2021
$264K
CLINICAL RESEARCH
2021
$244K
PUBLIC HEALTH SCIENCES
2021
$204K
Subaward
2021
$124K
RESEARCH
2021
$100K
RESEARCH SUPPORT
2021
$90K
For grant recipient's exempt purposes
2021
$90K
For grant recipient's exempt purposes
2021
$60K
NREF Clinical Fellowship Grant - Globus Medical
2021
$58K
Research
2021
$56K
SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
2021
$47K
CLINICAL RESEARCH
2021
$30K
MEDICAL/SCIENTIFIC RESEARCH & PROGRAMS
2021
$25K
SARCOMA FUND AWARD
2021
$7K
VACCINE AND INFECTIOUS DISEASE
2021
$612K
PUBLIC HEALTH SCIENCES
2020
$500K
SUBAWARD - SPONSORED RESEARCH
2020
$303K
CLINICAL RESEARCH
2020
$279K
SUPPORT CHARITABLE PROGRAMS
2020
$270K
CANCER RESEARCH
2020
$225K
research SUPPORT
2020
$157K
SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
2020
$124K
For grant recipient's exempt purposes
2020
$100K
Subaward
2020
$97K
CANCER RESEARCH
2020
$62K
Support of research activities
2020
$53K
RESEARCH
2020
$49K
VACCINE AND INFECTIOUS DISEASE
2020
$18K
MEDICAL/SCIENTIFIC RESEARCH & PROGRAMS
2020
$10K
GENERAL OPERATING SUPPORT
2020
$5K
GENERAL PURPOSE
2020
$5K
RESEARCH SUBAWARD
2020
$608K
SUBAWARD - SPONSORED RESEARCH
2019
$480K
PUBLIC HEALTH SCIENCES
2019
$205K
SUPPORTED BASIC AND CLINICAL RESEARCH IN CANCER PERFORMED AT MSKCC AND RESULTING IN MORE THAN 15 PEER REVIEWED SCIENTIFIC PUBLICATIONS.
2019
$174K
CLINICAL RESEARCH
2019
$76K
Support of research activities
2019
$72K
For grant recipient's exempt purposes
2019
$42K
VACCINE AND INFECTIOUS DISEASE
2019
$38K
Subaward
2019
$33K
VACCINE AND INFECTIOUS DISEASE
2019
$15K
MEDICAL/SCIENTIFIC RESEARCH & PROGRAMS
2019
$8K
TO SUPPORT RESEARCH
2019
$519
VACCINE AND INFECTIOUS DISEASE
2019
$963K
PUBLIC HEALTH SCIENCES
2018
$459K
CANCER RESEARCH
2018
$346K
CLINICAL RESEARCH
2018
$216K
MEMORIAL SLOAN-KETTERING CANCER CENTER ("MSKCC") ($215,795) -A) SUPPORT THE RESEARCH AND CLINICAL STUDIES FOR RETINOBLASTOMA ($150,000): THESE FUNDS SUPPORTED THE RESEARCH CONDUCTED AT MSK DURING THE YEAR. IT RESULTED IN 16 PUBLICATIONS IN PEER REVIEWED JOURNALS INCLUDING THE BRITISH JOURNAL OF OPHTHALMOLOGY, OPHTHALMOLOGY, AMERICAN JOURNAL OF OPHTHALMOLOGY, NEOPLASIA, PLOS1, INT J OF RETINA AND VITREOUS, JAMA OPHTHALMOLOGY, OPHTHALMIC GENETICS AND IOVS. THE TOTAL NUMBER OF AUTHORS SUPPORTED BY THESE FUNDS IN 2018 WAS 52.B) CYCLE FOR SURVIVAL ($55,000): DONATION TO THE CYCLE CHARITY-THE YEARLY FUND RAISER AT MSK TO SUPPORT RESEARCH IN RARE CANCERS.C) RESEARCH EQUIPMENT AND SUPPLIES ($10,795): COMPUTERS, STATISTICIANS, REPRINTS, PRODUCTION OF SCIENTIFIC ARTICLES AND ONGOING RESEARCH AT MSK, INCLUDING CHARGES BY LABS FOR PROCESSING SPECIMENS FOR RESEARCH.
2018
$162K
For grant recipient's exempt purposes
2018
$86K
Medical Research
2018
$33K
VACCINE AND INFECTIOUS DISEASE
2018
$26K
RESEARCH
2018
$13K
GENERAL OPERATING
2018
$13K
UNRESTRICTED SUPPORT
2018
$12K
RESEARCH SUBAWARD
2018
$8K
To provide leadership in the prevention, treatment and cure of cancer through excellence, vision and cost effectiveness in patient care, outreach programs, research, and education.
2018
$2.3M
PUBLIC, SOCIETAL BENEFIT
2017
$977K
PUBLIC HEALTH SCIENCES
2017
$191K
FOR GRANT RECIPIENT'S EXEMPT PURPOSES
2017
$190K
CLINICAL RESEARCH
2017
$184K
Support of research activities
2017
$65K
SUBAWARD
2017
$24K
Medical Research
2017
$23K
RESEARCH SUBAWARD
2017
$11K
RESEARCH
2017
$7K
VACCINE AND INFECTIOUS DISEASE
2017
$68K
PassThrough Fed Proj
2016

Funded by

$46.5M from 52 funders · 163 grants · 2016–2024

Cancer Research Institute Inc

$8.5M · 6 grants · 2018–2023

National Philanthropic Trust

$5.9M · 4 grants · 2017–2023

Fred Hutchinson Cancer Research Center

$5.2M · 19 grants · 2017–2021

American Cancer Society Inc

$5.0M · 3 grants · 2022–2024

Conquer Cancer Foundation Of The

$4.2M · 3 grants · 2020–2024

Fred Hutchinson Cancer Center

$2.3M · 7 grants · 2021–2023

Swim Across America Inc

$1.7M · 4 grants · 2020–2024

Ira Sohn Conference Foundation

$1.5M · 4 grants · 2020–2023

Details

EIN131624182
NTEE codeH30Z
Subsection03
Ruling date1962-01
MEMORIAL SLOAN-KETTERING CANCER CENTER — Mission, Financials & Grants Received | Grantivo